IMM Immupharma Plc

TIDMIMM

Immupharma PLC

07 September 2012

 
 FOR IMMEDIATE RELEASE   7 SEPTEMBER 2012 
 

RNS REACH

ImmuPharma to Present at

Rodman and Renshaw Annual Global Investment Conference, New York

Tuesday 11 September 2012

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to confirm that it will be presenting at the Rodman and Renshaw Annual Global Investment Conference on Tuesday 11 September 2012 at the Waldorf Astoria in New York City. Tracy Weimar, Vice President, Operations and Finance will present an overview of ImmuPharma at 16:55 PM Eastern Time.

If you would like to arrange a one to one meeting with ImmuPharma during this conference between 10-12 September, please do not hesitate to contact either Tracy Weimar or Lisa Baderoon, Head of Investor Relations.

Ends

For further information please contact:

 
 ImmuPharma PLC (www.immupharma.com) 
 Tracy Weimar, Vice President, Operations 
  and Finance 
  tracy.weimar@immupharma.com                 +44 020 7152 4080 
 Lisa Baderoon, Head of Investor Relations 
  Lisa.baderoon@immupharma.com                +44 7721 413 496 
 Buchanan                                     + 44 20 7466 5000 
 Mark Court 
 

Notes to Editors

ImmuPharma

ImmuPharma is focusing on developing novel medicines with high sales potential in specialist markets with serious unmet need. ImmuPharma has five drug candidates in development, two platform technologies and approximately 70 patents. The Company's most advanced drug candidate, Lupuzor(TM) a potential blockbuster drug for Lupus, a chronic autoimmune disease has recently received the approval from the US FDA to enter phase III with a Special Protocol Assessment and "Fast Track" designation. ImmuPharma was founded and is led by a commercially focused Board and management team with extensive experience. www.immupharma.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRASSFFSWFESEFU

Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024